Currently out of the existing stock ratings of Andrew Cooper, 121 are a BUY (90.3%), 12 are a HOLD (8.96%), 1 are a SELL (0.75%).

Andrew Cooper

Work Performance Price Targets & Ratings Chart

Analyst Andrew Cooper, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 56.52% that have a potential upside of 24.31% achieved within 168 days.

Andrew Cooper’s has documented 250 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on MYGN, Myriad Genetics at 25-Feb-2025.

Wall Street Analyst Andrew Cooper

Analyst best performing recommendations are on PROG (PROGENITY).
The best stock recommendation documented was for VCYT (VERACYTE) at 11/4/2022. The price target of $27 was fulfilled within 6 days with a profit of $2.62 (10.75%) receiving and performance score of 17.91.

Average potential price target upside

of $81.64 (17.27%) on TMO (THERMO FISHER SCIENTIFIC).
of $37.4 (17.8%) on DHR (DANAHER).
of $20 (38.04%) on EXAS (EXACT SCIENCES).

CDNA Caredx CVET Covetrus EXAS EXACT Sciences NEO NeoGenomics NVTA Invitae Corp OSUR OraSure Technologies PROG Progenity QDEL Quidel VCYT Veracyte AVTR Avantor HAE Haemonetics HOLX Hologic LMDX LumiraDx Ltd MYGN Myriad Genetics NTRA Natera DHR Danaher GH Guardant Health TMO Thermo Fisher Scientific

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Yi Chen (HC WAINWRIGHT)